-
公开(公告)号:WO2009136995A2
公开(公告)日:2009-11-12
申请号:PCT/US2009002401
申请日:2009-04-16
Applicant: PORTOLA PHARM INC , JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
CPC classification number: C07D239/48 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: The present invention is directed to compounds of formula I-V and tattooers thereof or pharmaceutically acceptable salts, esters, and pro drugs thereof which are inhibitors of sky kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as undesired thrombosis and Non Hodgkin's Lymphoma.
Abstract translation: 本发明涉及作为天sky素抑制剂的式I-V化合物及其纹身或其药学上可接受的盐,酯和其前体药物。 本发明还涉及用于制备这种化合物的中间体,这种化合物的制备,含有这种化合物的药物组合物,抑制syk激酶活性的方法,抑制血小板聚集的方法,以及预防或治疗数字的方法 至少部分通过syk激酶活性介导的病症,例如不期望的血栓形成和非霍奇金淋巴瘤。
-
公开(公告)号:CA2728893C
公开(公告)日:2017-03-14
申请号:CA2728893
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , JIA ZHAOZHONG J , ROSE JACK W
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods ofinhibilion the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as cardiovascular disease, inflammatory disease and autoimune disease and cell proliferative disorder. Formula (I) Y1 is selected from the group consisting of: (a) and (b); Z is O or S; D1 is selected from the group consisting of: (a) phenyl substituted with a group, R5 (b) naphthyl (c) C3-8cycloalkyl (d) heteroaryl (e) heterocyclyl
-
公开(公告)号:HRP20161310T1
公开(公告)日:2016-12-02
申请号:HRP20161310
申请日:2016-10-11
Applicant: PORTOLA PHARM INC
Inventor: BAUER SHAWN M , JIA ZHAOZHONG J , SONG YONGHONG , XU QING , MEHROTRA MUKUND , ROSE JACK W , HUANG WOLIN , VENKATARAMANI CHANDRASEKAR , PANDEY ANJALI
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12
-
公开(公告)号:ES2546502T3
公开(公告)日:2015-09-24
申请号:ES09742982
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , ROSE JACK W
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: Un compuesto que tiene la fórmula (I):**Fórmula** o uno de sus tautómeros o sales farmacéuticamente aceptables, en donde: D1 es fenilo sustituido con heteroarilo; cada E1 está seleccionado de modo independiente del grupo que consiste en alquilo C1-8, alquenilo C2-8, alquinilo C2-8, alcoxi C1-8, alquil C1-8-tio, aminocarbonilo, alcoxi C1-8-carbonil-alquileno C1-8, alcoxi C1-8-carbonil C1-8alcoxi C1-8, alcoxi C1-8-carbonilamino, oxo, halo, ciano, haloalquilo C1-8, haloalcoxi C1-8, aminosulfonilo, heteroarilsulfinilo; amino, hidroxilo, arilalquileno C1-8, fenilo, aminoalquilo C1-8, aminocicloalquilo C3-8, heterociclilo, heteroarilo, acilo C1-8, alquil C1-8 sulfonilo, acilamino y heterociclilalquileno C1-8; el subíndice n es 0, 1, 2, 3 ó 4; el resto:**Fórmula** es bien: (a)**Fórmula** y donde X e Y están seleccionados independientemente del grupo que consiste en: CH2, NH, NCOOH3 y S; (b) seleccionado del grupo que consiste en:**Fórmula** y donde cada R8a y R8b es independientemente H, hidroxilo, halo o si están en carbonos adyacentes, pueden combinarse con los átomos a los que están unidos para formar un anillo de benceno fusionado; y cada R9a y R9b es independientemente H, hidroxilo, halo o si están en carbonos adyacentes, pueden combinarse con los átomos a los que están unidos para formar un anillo de benceno fusionado; y la línea ondulada indica el punto de unión al resto de la molécula; o**Fórmula** (c) donde cada R8a y R8b es independientemente H o pueden combinarse con los átomos a los que están unidos para formar un anillo de benceno fusionado; y la línea ondulada indica el punto de unión al resto de la molécula; y "cicloalquilo" se refiere a un grupo hidrocarbonado mono o policíclico alifático, que puede formar un anillo con puente o un anillo espiro, y que puede tener uno o más enlaces dobles o triples.
-
公开(公告)号:AU2009244897B2
公开(公告)日:2014-11-13
申请号:AU2009244897
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: MEHROTRA MUKUND , HUANG WOLIN , SONG YONGHONG , JIA ZHAOZHONG J , XU QING , VENKATARAMANI CHANDRASEKAR , BAUER SHAWN M , PANDEY ANJALI , ROSE JACK , KANE BRIAN
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods ofinhibilion the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as cardiovascular disease, inflammatory disease and autoimmune disease and cell proliferative disorder. Formula (I) Y
-
公开(公告)号:EA019973B1
公开(公告)日:2014-07-30
申请号:EA201001618
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , ROSE JACK W
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: Изобретениенаправленонасоединенияформул I-V иихтаутомерыилиихфармацевтическиприемлемыесоли, сложныеэфирыи пролекарства, которыеявляютсяингибиторамикиназы Syk. Изобретениетакженаправленонапромежуточныесоединения, используемыедляполучениятакихсоединений, получениетакихсоединений, фармацевтическиекомпозиции, содержащиетакиесоединения, способыингибированияактивности Syk-киназы, способыингибированияагрегациитромбоцитов, испособыпредотвращенияилилечениярядасостояний, опосредованных, поменьшеймере, частичноактивностью Syk-киназы, такойкакнежелательныйтромбозози неходжкинскаялимфома.
-
公开(公告)号:SG2014015085A
公开(公告)日:2014-06-27
申请号:SG2014015085
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , ROSE JACK W
-
8.
公开(公告)号:HK1155452A1
公开(公告)日:2012-05-18
申请号:HK11109813
申请日:2011-09-19
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , ROSE JACK W
IPC: C07D20060101 , A61K20060101 , A61P20060101
Abstract: The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as undesired thrombosis and Non Hodgkin's Lymphoma.
-
公开(公告)号:VN29259A1
公开(公告)日:2012-04-25
申请号:VN201003064
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: MEHROTRA MUKUND , HUANG WOLIN , SONG YONGHONG , JIA ZHAOZHONG J , XU QING , VENKATARAMANI CHANDRASEKAR , BAUER SHAWN M , PANDEY ANJALI , ROSE JACK W , KANE BRIAN
-
公开(公告)号:CO6331450A2
公开(公告)日:2011-10-20
申请号:CO10143182
申请日:2010-11-16
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , KANE BRIAN J , ROSE JACK , PANDEY ANJALI , BAUER SHAWN M , XU QING , SONG YONGHONG , MEHROTRA MUKUND , HUANG WOLIN
IPC: A61K31/506 , A61P35/00 , C07D417/12
Abstract: La presente invención está dirigida a compuestos de fórmula I-V y tautómeros correspondientes o sales farmacéuticamente aceptadas, ésteres y profármacos correspondientes que actúan como inhibidores de quinasa syk, La presente invención también está dirigida a intermediarios utilizados en la elaboración de dichos compuestos, la preparación de dichos compuestos, composiciones farmacéuticas que contienen dichos compuestos, métodos para inhibir la activada de quinasa syk, métodos para inhibir la acumulación de plaquetas y métodos para prevenir o tratar una cantidad de enfermedades mediadas al menos parcialmente por actividad de quinasa syk, como enfermedades cardiovasculares, enfermedades inflamatorias, enfermedades autoinmunes y trastornos proliferativos de células. La Fórmula (I) Y1 es seleccionada del grupo que consiste en: (a) y (b), Z es O o S, D1 es seleccionada del grupo que consiste en: (a) fenilo sustituido por un grupo, R5 (b) naftilo (c) C3-8cicloalquilo (d) heteroarilo (e) heterociclilo.
-
-
-
-
-
-
-
-
-